Orkla As A S/Adr

Good morning, and welcome to Orkla's presentation of third quarter results. My name is Annie Bersagel, and I'm the new head of investor relations. To begin, our president and CEO, Niels Zelta, will begin with a summary of the quarter. After that, our CFO, Eiravid Eglund, will go into a deeper dive of the financials. Before we move on to Q&A, Niels will summarize some of the main messages from the quarter. Just a bit of housekeeping. So during the presentation, you're welcome to submit questions in the webcast. And we will address all your questions in the Q&A session at the end of the presentation. So I'll now leave the floor to you, Nils.

Thank you, Annie. And good morning, everyone. Overall, in Q3, we continued to improve profitability and cash flow. Adjusted earnings per share were up 10%, with underlying EBITDA just growth of 17% for the consolidated portfolio companies, including headquarters. This comes despite significantly increased advertising and promotional spending during the quarter. Organic growth was 3.9% in the quarter, with positive contribution from 8 of 10 consolidated portfolio companies. On a macro level, inflation rates continued to normalize in many of our markets. Competition from private labor remains high, and some markets were negatively impacted by weak consumer sentiment. We nevertheless see that the challenges associated with weak consumer purchasing power have eased somewhat compared to the same quarter last year. As we said, in Q2, the development in raw material prices remains polarized, but we see slight positive effects in our Q3 figures. Based on what we see today going into 2025, We expect raw material prices, in sum, to stabilize, excluding cocoa. Lastly, turning to cash flow. Under the new operating model, we lifted cash conversion as a key metric for the companies, and we are seeing positive effects. Arve will revert to this later in the presentation. As I said, underlying EBIT adjust was up 70% for the company as a whole. Let me give you a few comments on the largest portfolio companies. Jotunn continued to perform well ahead of the company's communicated financial targets. Sales growth was 8% year-to-date for August, despite strong comparables. Jotun's return on capital employed was 34% on a rolling 12-month basis. For Orkla Food Europe, volume growth was slightly positive for the quarter, with variation across the markets. Operating margins in Food Europe continued to improve, supported by ongoing costs reduction, and in September, Akku Wikström joined as a new CEO for the company. I'm very happy to have Akku on board. For Orkla Confection Snacks, operational challenges at the biscuit factory are now largely resolved. We see a positive market share development overall, and in terms of volume, we see pressure on the chocolate category. following an extraordinary increase in market prices for cocoa. For Orkla Food Ingredients, operating margin growth and volume mix growth were positive for both the bakery and sweet segments. The company's performance was especially strong in the bakery segment, both in terms of volume and margin development. Returning to our targets from the capital markets day. The three targets on this slide represent the aggregate effects of the portfolio companies reaching their targets over the strategy period. Although it's still early days, we are on track on each of these metrics. I will now hand over to Arve for more details on the financials.

Thank you, Nils, and good morning, everyone. The third quarter was a strong quarter for Orkla, with a 4.3% operating growth increase to 17.5 billion, and an EBIT adjust growth of 13%. EBIT for the consolidated portfolio companies, including HQ, increased by 17%, driven by strong underlying growth and improved margins for most of our portfolio companies. The decline in EBITDA just for financial investments was mainly related to the handover of apartments in Orkla real estate last year. Then on the other income and expenses, we have a negative number of 741 million this quarter. 650 million of this is related to three specific write-down. Firstly, we have done a 300 million impairment of Orkla Confectional Stacks Latvia. So this is not the biscuit factory, but the business unit acquired back in 2015, which has not shown the necessary profitability to defend the book value of intangibles in the balance sheet. The same reasoning is behind a 50 million Brighton of Nick Germany, a part of the sweet segment in Orkla food ingredients. And lastly, we have done a 300 million write-down of a common ERP template, which was developed under the former strategy of Orkla, developing a common ERP system for all group companies, which has not the same relevance now with more independent portfolio companies. On that basis, the system is taken down from 360 to 60 million on the balance sheet. And please note that these write-downs have no cash effect. Profit from Jotun amounted to 548 million in the quarter, an increase by 8% compared to last year. And the increase in profit to non-controlling interest is linked to Rowan's ownership in Oytla Food Ingredients. Reported earnings per share were 1.18%. while adjusted for other income and expenses is 1.77 per share, an increase of 10% compared to last year. Overall, we continue to see EBIT margins to tick upwards, reaching 10% on a rolling 12-month basis at the end of third quarter, and an increase of 30 basis points compared to last quarter. All of the largest portfolio companies experienced positive EBIT adjust margin growth, supported by positive volume mix development, despite of the higher advertising spend across the portfolio companies in line with strategy, as also Nils mentioned. Organic growth was 3.9% in the quarter, of which 2.6% volume mix positively affected by one additional sales day compared to last year. And as shown in the table to the right, the positive volume mix growth was broad based across the portfolio companies. At an aggregated level, we continue to see stabilizing market conditions following a period of high inflation pressure. Total cash flow before capital allocation year to date amounted to $4.9 billion, up $2.1 billion compared to last year. You'll notice a slightly different format to this cash flow than in previous quarter, focusing on the cash flow before capital allocation to M&A, CapEx, or distribution to owners. The increase in cash flow is mainly driven by EBIT growth in the consolidated portfolio companies, lower net replacement investments, higher dividend received from Jotun, lower taxes linked to profit in hydropower, but partly offset by reduced profits from financial investments. Cash flow from financial investments declined to approximately 500 million due to working capital buildup in Orkla Real Estate, handover of apartments in Orkla Real Estate last year, and reduced profits in hydropower. Cash conversion in the portfolio companies remained strong, on an aggregate 112% on a rolling 12-month basis. And we maintain a strong balance sheet supported by the increased cash flow as discussed on the previous slide, net cash flow from M&A, but also taking into account the increased dividend paid to shareholders in the second quarter. Net interest bearing debt was 18.3 billion at the end of the quarter. corresponding to a net interest-bearing debt to EBITDA of 1.8 times. And excluding external debt and EBITDA in Euclid food ingredients, the ratio was 1.4 times. Now let me walk you through the financial performance in the portfolio companies. Starting off with Jotunn, the company continues to deliver strong results with revenue growing 8% on a year-to-date basis, with growth across all segments and regions. Growth was particularly strong in the protective coatings with double-digit sales growth. The marine business also had good growth, while decorative paints and powder had a more modest development. EBITDA grew by 2.3% year-to-date, driven by positive volume growth on back of high demand in most geographical areas. Raw material prices have remained fairly stable, but the company is facing some inflationary pressure on operating costs going forward. However, the outlook for the remaining of the rest of the year is still positive. Ultra Foods Europe had an organic growth of 2.7% in the quarter, evenly split between price and volume mix. The volume mix growth is mainly driven by Norway, partly due to a weak July last year, but also positive out-of-home development this year. We have a continued market share growth in Denmark, and we had a comeback in retail in the Czech Republic following price reductions. We continue to experience demanding markets in Sweden and Finland, where the consumer sentiment remains muted. Despite the substantial increase in AMP spend compared to last year, underlying EBIT just grew by 17%, and EBIT margin was 1.6 percentage points. The increase is positively impacted by stronger focus on category and product profitability, supported by cost savings from reorganization projects in Norway, Sweden, and the Czech Republic. Note that the third quarter EBIT last year was negatively impacted by one of costs of approximately 25 million from recall of ketchup across several markets. Oetler confectioner snacks reported organic growth of 4.4 percent in a quarter driven by price as volumes were hampered by softening demand in the confectionery segments related to increased chocolate prices, as well as production issues at the Bubbs factory. These production issues are now resolved. In Q3, improvements at the biscuit factory contributed approximately 45 million to the EBIT growth. Even though the biscuit factory improvement was the key driver behind the 53 million underlying EBIT growth in the quarter, growth was still solid given the substantial increase in AMP spend compared to last year. And when it comes to COCO, we want to reiterate that volumes for 2024 are secured. We have also started to secure volumes into Q1 next year. And while cocoa prices have declined since the spring, they remain extraordinary high compared to historical levels. We continue to take mitigating actions to dampen the effect. Lastly, at Oracle Capital Markets Day last year, a redesigned operating model was presented. The transition to this new model is progressing well and is expected to be fully implemented by early next year. Orkla food ingredients delivered organic growth of 3.1%. Volume mix was positive at 4.1%, while prices declined slightly on back of input price reductions. The bakery segment continued its solid performance, driven by volume mix growth and price management. Volume in the sweet segment grew during the quarter, partly explained by weak comparables in Q3 last year for ice cream ingredients. We also see that the program of mitigating actions mentioned last quarter is progressing according to plan. We have a slight decline year-over-year for plant-based, but that's fully related to the margarine segment, where results were temporarily very strong in the second half of 2023, and in particular in the fourth quarter. The strong underlying EBIT adjust growth of 18% in the quarter can be explained by the organic growth in bakery and sweet. Moving on to Orkla Health. Orkla Health had an organic growth of 10% in the quarter due to broad-based price increases, combined with continued good momentum for Møllers and Jordan. We had a Maxime relaunch in Norway, as well as positive development for Riemann and our D2C business. Underlying EBIT adjust growth of 13% was driven by top line growth and favorable mix, but partly offset by increased investments in the AMP and commercial resources. This is in line with the growth strategy to accelerate international expansion for global brands and new market entries for NutraQ, as well as supporting our brands in our Nordic home markets. Organic growth in Orkla India was driven by positive volume mix development of 3.3% and negative price effects on back of input price reductions. The strong growth in the international business continues, while consumer sentiment in the domestic market was weak, combined with modest festive sales and distributor inventory reductions. Underlying EBITDA just growth was 8.4% in a quarter, driven by contribution margin improvement and reduction in fixed cost, but partially offset by higher advertising cost. European pizza company reported an organic growth of 2.3% in a quarter. The Grasso in Poland continues to show positive momentum, while consumer sales in Finland and the Netherlands remain soft. The strong focus on pricing and cost control contributed to underlying EBITDA just growth of 23%. But growth was also positively affected by the turnaround in New York, Pisa, Germany, which is now operating at a smaller but more healthy base. Orkla Home and Personal Care achieved an organic growth of 4% in the quarter, driven by increased volumes in contract manufacturing, meaning manufacturing products on behalf of external customers. Underlying EBIT Adjust increased by 25%, driven by revenue management and lower input prices, but partly offset by higher advertising spend. Turning to the remaining portfolio companies in the transform or exit category, all three of them experienced challenging market conditions during the quarter. But I'm impressed that Orkla Healthcare nevertheless continued to perform in line with the company's financial targets, delivering 17% EBIT growth in the quarter driven by improved cost efficiency, as well as onboarding a new customer and successful campaigns. Then I would like to give the floor back to you, Nils.